As expected, NIR-PIT employing an analog of GLP-1 can specifically bind and kill GLP-1R-positive cells, providing a new, effective, and minimally invasive approach to normalize blood glucose levels in patients with hyperinsulinemic hypoglycemia 185. The gene discussed is GLP1R; the disease is hyperinsulinemic hypoglycemia.